215 related articles for article (PubMed ID: 1320047)
1. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells.
Hellmér J; Marcus C; Sonnenfeld T; Arner P
J Clin Endocrinol Metab; 1992 Jul; 75(1):15-20. PubMed ID: 1320047
[TBL] [Abstract][Full Text] [Related]
2. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism.
Hellström L; Wahrenberg H; Reynisdottir S; Arner P
J Clin Endocrinol Metab; 1997 Jan; 82(1):159-66. PubMed ID: 8989252
[TBL] [Abstract][Full Text] [Related]
3. Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells.
Hoffstedt J; Shimizu M; Sjöstedt S; Lönnqvist F
Obes Res; 1995 Sep; 3(5):447-57. PubMed ID: 8521164
[TBL] [Abstract][Full Text] [Related]
4. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet.
Hellström L; Reynisdottir S; Langin D; Rössner S; Arner P
Int J Obes Relat Metab Disord; 1996 Aug; 20(8):745-52. PubMed ID: 8856398
[TBL] [Abstract][Full Text] [Related]
5. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.
Van Harmelen V; Lönnqvist F; Thörne A; Wennlund A; Large V; Reynisdottir S; Arner P
Int J Obes Relat Metab Disord; 1997 Nov; 21(11):972-9. PubMed ID: 9368819
[TBL] [Abstract][Full Text] [Related]
6. Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.
Lönnqvist F; Wahrenberg H; Hellström L; Reynisdottir S; Arner P
J Clin Invest; 1992 Dec; 90(6):2175-86. PubMed ID: 1334970
[TBL] [Abstract][Full Text] [Related]
7. Is visceral adiposity a significant correlate of subcutaneous adipose cell lipolysis in men?
Mauriège P; Brochu M; Prud'homme D; Tremblay A; Nadeau A; Lemieux S; Després JP
J Clin Endocrinol Metab; 1999 Feb; 84(2):736-42. PubMed ID: 10022446
[TBL] [Abstract][Full Text] [Related]
8. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men.
Hoffstedt J; Arner P; Hellers G; Lönnqvist F
J Lipid Res; 1997 Apr; 38(4):795-804. PubMed ID: 9144094
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M
Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying regional differences in lipolysis in human adipose tissue.
Wahrenberg H; Lönnqvist F; Arner P
J Clin Invest; 1989 Aug; 84(2):458-67. PubMed ID: 2503539
[TBL] [Abstract][Full Text] [Related]
11. Influence of androgenic status on the alpha 2/beta-adrenergic control of lipolysis in white fat cells: predominant alpha 2-antilipolytic response in testosterone-treated-castrated hamsters.
Pecquery R; Leneveu MC; Giudicelli Y
Endocrinology; 1988 Jun; 122(6):2590-6. PubMed ID: 2453344
[TBL] [Abstract][Full Text] [Related]
12. [Adrenergic lipolysis in human fat cells: properties and physiological role of alpha-adrenergic receptors (author's transl)].
Berlan M; Lafontan M; Dang Tran L
J Physiol (Paris); 1980; 76(2):133-46. PubMed ID: 6249915
[TBL] [Abstract][Full Text] [Related]
13. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
Hellström L; Rössner S; Hagström-Toft E; Reynisdottir S
Int J Obes Relat Metab Disord; 1997 Apr; 21(4):314-20. PubMed ID: 9130030
[TBL] [Abstract][Full Text] [Related]
14. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives.
Hellström L; Langin D; Reynisdottir S; Dauzats M; Arner P
Diabetologia; 1996 Aug; 39(8):921-8. PubMed ID: 8858214
[TBL] [Abstract][Full Text] [Related]
15. Changes in catecholamine-induced lipolysis in isolated human fat cells during the first year of life.
Marcus C; Karpe B; Bolme P; Sonnenfeld T; Arner P
J Clin Invest; 1987 Jun; 79(6):1812-8. PubMed ID: 3034983
[TBL] [Abstract][Full Text] [Related]
16. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.
Lönnqvist F; Thöme A; Nilsell K; Hoffstedt J; Arner P
J Clin Invest; 1995 Mar; 95(3):1109-16. PubMed ID: 7883959
[TBL] [Abstract][Full Text] [Related]
17. Effects of lipolytic and antilipolytic agents on glucose transport in human fat cells.
Arner P; Goldinger M; Marcus C; Engfeldt P
Int J Obes; 1991 May; 15(5):327-31. PubMed ID: 1653187
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a functional beta 3-adrenoceptor in man.
Lönnqvist F; Krief S; Strosberg AD; Nyberg S; Emorine LJ; Arner P
Br J Pharmacol; 1993 Nov; 110(3):929-36. PubMed ID: 7905344
[TBL] [Abstract][Full Text] [Related]
19. Adipose tissue metabolism in young and middle-aged men after control for total body fatness.
Imbeault P; Prud'Homme D; Tremblay A; Després JP; Mauriège P
J Clin Endocrinol Metab; 2000 Jul; 85(7):2455-62. PubMed ID: 10902793
[TBL] [Abstract][Full Text] [Related]
20. Omental and epigastric adipose tissue lipolytic activity in human obesity. Effect of abdominal fat distribution and relationship with hyperinsulinemia.
Busetto L; Digito M; Dalla Montá P; Carraro R; Enzi G
Horm Metab Res; 1993 Jul; 25(7):365-71. PubMed ID: 8406322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]